Open AccessA prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy
Author(s) -
Hsiang-Chen Hsieh,
Shu-Chen Hung,
Sheng-Yang Huang,
FangLiang Huang,
Chia-Man Chou
Publication year - 2021
Publication title -
journal of the chinese medical association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 42
eISSN - 1728-7731
pISSN - 1726-4901
DOI - 10.1097/jcma.0000000000000601
Subject(s) - medicine , catheter , heparin , occlusion , surgery , anesthesia , prospective cohort study , urokinase
The totally implanted vascular access device (TIVAD) is commonly used in patients with malignant tumors requiring chemotherapy or long-term intravenous infusion and those with difficulty placing peripheral venous catheters. It could also be used to draw blood in pediatric patients. Thus, how to maintain the patency and longevity of TIVAD is always emphasized.